StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences cash

Cash and short-term investments held at the end of each period.

Accustem Sciences's cash was $12.93K at Jun 30, 2026. For fiscal 2025 it was $13.93K, up 176.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.93K+176.0%
FY2024Dec 31, 2024$5.05K-76.5%
FY2023Dec 31, 2023$21.48K-97.1%
FY2022Dec 31, 2022$733.98K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.93K-58.8%
Q1 FY2026Mar 31, 2026$12.21K-66.4%
Q4 FY2025Dec 31, 2025$13.93K+176.0%
Q3 FY2025Sep 30, 2025$14.39K-61.2%
Q2 FY2025Jun 30, 2025$31.34K-32.0%
Q1 FY2025Mar 31, 2025$36.38K+288.1%
Q4 FY2024Dec 31, 2024$5.05K-76.5%
Q3 FY2024Sep 30, 2024$37.08K-47.8%
Q2 FY2024Jun 30, 2024$46.07K-61.8%
Q1 FY2024Mar 31, 2024$9.37K-94.8%
Q4 FY2023Dec 31, 2023$21.48K-97.1%
Q3 FY2023Sep 30, 2023$71.01K-94.7%
Q2 FY2023Jun 30, 2023$120.65K-93.9%
Q1 FY2023Mar 31, 2023$180.64K-94.4%
Q4 FY2022Dec 31, 2022$733.98K–
Q3 FY2022Sep 30, 2022$1.33M–
Q2 FY2022Jun 30, 2022$1.98M–
Q1 FY2022Mar 31, 2022$3.24M–

More Accustem Sciences figures

See a number that looks wrong?